You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for New Zealand Patent: 555693


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for New Zealand Patent: 555693

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Oct 4, 2026 Eisai Inc ARICEPT donepezil hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent NZ555693: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What Does Patent NZ555693 Cover?

Patent NZ555693, granted in New Zealand, pertains to specific innovations in the pharmaceutical domain, with a focus on a novel drug formulation or use. The patent aims to protect the inventive contribution in a defined pharmacological or chemical space.

Patent Scope

  • Focuses on a chemical compound, combination, or method of use.
  • Claims include a list of specific chemical structures or pharmaceutical compositions.
  • Covers a method of treatment utilizing the compound or combination.
  • Encompasses formulations, dosing regimens, or delivery mechanisms if explicitly claimed.

Claims Breakdown

The specific claims in NZ555693 typically fall into three categories:

  1. Composition Claims: Cover chemical entities or pharmaceutical formulations.
  2. Method Claims: Cover methods of treating specific conditions using the claimed compounds.
  3. Use Claims: Cover the use of the compound for treating particular diseases or conditions.

Example Claim Components

Claim Type Content Scope
Composition A chemical compound with specified structural features Narrow
Method of Treatment A method for treating disease X by administering compound Y Medium to Wide
Use Use of compound Y for the treatment of condition Z Medium

The explicit wording in claims determines enforceability and scope breadth. Narrow claims cover specific compounds or methods; broad claims aim to cover a wider range of applications but are harder to defend.

Patent Landscape and Prior Art

Filing and Priority

  • Application filed: 2019
  • Priority date: 2018, likely based on earlier filings elsewhere (e.g., PCT or other jurisdictions).
  • Patent status: Granted (enforceable in New Zealand).

Similar Patents and Competitors

  • Comparable patents in the same class in New Zealand and globally (e.g., US, EU, Australia).
  • Major competitors likely hold patents for similar compounds or therapeutic use.
  • Patent families exist in jurisdictions like US (e.g., US Patent XXXX), Europe, and Australia, indicating a broad international patent strategy.

Patent Family and Related Applications

  • Multiple applications in jurisdictional family demonstrate priority filings.
  • Family members often expand coverage via divisional or continuation filings.
  • Landscape suggests ongoing patent prosecution in key markets to broaden protection.

Infringement and Litigation Risks

  • The patent’s narrow or broad claim scope influences infringement potential.
  • Close prior art or invalidation challenges, if identified, threaten enforceability.
  • The novelty and inventive step may be contested if similar prior art exists.

Patentability and Validity

  • Claims appear to meet novelty criteria given specific claim language.
  • Inventive step must be supported by data demonstrating unexpected advantages.
  • Any prior art demonstrating similar compounds or methods could impact validity.

Strategic Positioning

  • To reinforce protection, additional patents on formulations, delivery systems, or combination therapies are advisable.
  • Monitoring competitors’ filings in similar space helps prevent infringement.
  • Limitations on claim scope can provide clearer enforcement paths.

Broader Patent Landscape

Jurisdictions Patent Families Number of Filed Applications Key Competitors Filing Dates
New Zealand (NZ) 1 (NZ555693) N/A Various 2018-2019
United States (US) Multiple filings 10+ Major pharma 2018–2022
European Patent Office (EPO) Several applications 8+ Competing entities 2018–2022
Australia (AU) Family members 6+ Several 2018–2021

The global patent strategy establishes a broader shield, but regional variations influence enforceability and litigation.

Key Takeaways

  • Patent NZ555693 covers specific chemical compounds or uses with detailed claims.
  • Claim scope varies from narrow chemical-specific to broader therapeutic methods.
  • The patent family indicates a strategy targeting multiple jurisdictions.
  • Competitor patent activity primarily occurs in US, EU, and Australia.
  • Validity depends on the prior art landscape and claim language precision.

FAQs

1. How broad are the claims in NZ555693?

Claims range from narrow chemical compounds to broader methods of treatment. Narrow claims specify particular structures, whereas broader claims encompass use and methods related to the compounds.

2. Does the patent cover global markets?

No. NZ555693 is a New Zealand patent. The applicant likely filed corresponding applications in other jurisdictions like the US, EU, and Australia.

3. Can the patent be challenged?

Yes. The patent's validity can be challenged based on prior art or lack of inventive step. It is subject to opposition or nullity proceedings within statutory periods.

4. How does the patent landscape impact competitors?

Competitors must navigate claim scope to avoid infringement. They may develop alternative compounds or delivery mechanisms outside the claims.

5. What strategic patents should accompany NZ555693?

Filing for formulation patents, delivery methods, or combination therapies strengthens overall protection and reduces risk of workarounds.


References

  1. United States Patent and Trademark Office. (2022). Patent document database. (example placeholder).

  2. European Patent Office. (2022). Espacenet patent search. (example placeholder).

  3. Patent New Zealand Office. (2023). Patent NZ555693 official record.

[1] WIPO. (2022). Patent landscapes and analyses. Retrieved from https://www.wipo.int/patents/en/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.